ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · IEX Real-Time Price · USD
9.17
+0.28 (3.15%)
At close: May 22, 2024, 4:00 PM
9.00
-0.17 (-1.85%)
After-hours: May 22, 2024, 6:35 PM EDT

ORIC Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018
Selling, General & Admin
25.6125.0922.0113.425.73
Upgrade
Research & Development
85.1761.6856.8635.9222.84
Upgrade
Other Operating Expenses
05024.840
Upgrade
Operating Expenses
110.7891.7778.8774.1928.57
Upgrade
Operating Income
-110.78-91.77-78.87-74.19-28.57
Upgrade
Other Expense / Income
-10.08-2.65-0.16-0.48-1.69
Upgrade
Pretax Income
-100.7-89.12-78.72-73.7-26.88
Upgrade
Net Income
-100.7-89.12-78.72-73.7-26.88
Upgrade
Shares Outstanding (Basic)
514038222
Upgrade
Shares Outstanding (Diluted)
514038222
Upgrade
Shares Change
29.75%4.48%72.97%1055.26%9.53%
Upgrade
EPS (Basic)
-1.96-2.25-2.07-3.36-14.15
Upgrade
EPS (Diluted)
-1.96-2.25-2.07-3.36-14.15
Upgrade
Free Cash Flow
-86.54-77.22-60.48-45.94-24.3
Upgrade
Free Cash Flow Per Share
-1.68-1.95-1.59-2.09-12.79
Upgrade
EBITDA
-99.67-88.16-77.82-72.73-25.86
Upgrade
Depreciation & Amortization
1.030.970.90.971.03
Upgrade
EBIT
-100.7-89.12-78.72-73.7-26.88
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).